TeraRecon unveiled the latest release of the company’s flagship iNtuition enterprise viewing solutions in combination with the second-generation of its iNteract+ interoperability platform at the annual European Congress of Radiology (ECR) meeting, March 4-8 in Vienna.


NYU Langone Medical Center has announced the creation of a new multidisciplinary Venous Thromboembolic Disease Center (VTEC) to treat those with life-threatening blood clots. The new VTEC delivers advanced detection, comprehensive care and effective management for patients experiencing a venous thromboembolic event.



Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute (DCRI).


The U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders to use while performing cardiopulmonary resuscitation (CPR) on cardiac arrest patients. The devices may improve the patient’s chances of surviving cardiac arrest.

March 9, 2015 — Boston Scientific Corp. announced the settlement of the breach of merger agreement lawsuit brought by Johnson & Johnson against Guidant Corporation, stemming from Boston Scientific's acquisition of Guidant. In the lawsuit filed in 2006, Johnson & Johnson alleged that Guidant breached the merger agreement it had with Johnson & Johnson, and sought more than $7 billion in damages. Guidant disputed the allegations.

Biotronik announced the presentation of data from the iliac arm of the BIOFLEX-I clinical trial at the Cardiovascular Research Technologies (CRT) conference in Washington, D.C. The BIOFLEX-I trial is designed to support U.S. Food and Drug Administration (FDA) approval of the Astron self-expanding nitinol stent to treat patients suffering from common iliac or external iliac artery disease.

Subscribe Now